MediConnect aims to reduce the problems of overprescription, counterfeit medication and addiction. The fact that they are a small company with limited backing makes this goal unlikely.

This is a redundant project idea as the NHS has launched an enquiry into these problems. Stating that their ICO can tackle the issue of addiction is sheer hype and is unrealistic.

Their Managing Director and founder is an ex-footballer with no experience in pharmaceuticals or technology. He would need experience in both of these to realise the project.

The project has very little to offer in terms of its goals.

We are very concerned when examining ICOs which have no supervision of funds, and no exit scam proofing.

MediConnect’s project is a risky investment. It has not been audited and no ICO Fund Supervision Scheme has been set up.